Skip to main content

Table 1 Demographics

From: Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled study

 

DFN-11

(n  =  131)

n (%)

Placebo

(n  =  137)

n (%)

Overall

(N  =  268)

n (%)

Age, yearsa

41.9 (12.5)

40.2 (12.3)

41.0 (12.4)

Sex

 Men

20 (15.3)

19 (13.9)

39 (14.6)

 Women

111 (84.7)

118 (86.1)

229 (85.4)

Race

 Asian

1 (0.8)

3 (2.2)

4 (1.5)

 Black/African-American

29 (22.1)

23 (16.8)

52 (19.4)

 Native Hawaiian or Other Pacific Islander

0 (0.0)

2 (1.5)

2 (0.7)

 White

98 (74.8)

105 (76.6)

203 (75.7)

 Other

3 (2.3)

4 (2.9)

7 (2.6)

Ethnicity

 Not Reported

0 (0.0)

1 (0.7)

1 (0.4)

 Hispanic or Latino

10 (7.6)

9 (6.6)

19 (7.1)

 Not Hispanic or Latino

121 (92.4)

127 (92.7)

248 (92.5)

Weight, kga

84.4 (23.9)

84.3 (23.6)

84.4 (23.7)

Height, cma

166.7 (8.4)

166.0 (8.7)

166.4 (8.5)

Body Mass Index, kg/m2a

30.4 (8.4)

30.7 (8.8)

30.6 (8.6)

  1. aMean (SD)